DSM Dyneema Names Motahari Pour to Succeed De Reuver as President


DSM Dyneema announced that Gerard de Reuver has elected to step down as President of DSM Dyneema after five years in the post on 1 August 2015. He will be succeeded by Golnar Motahari Pour, a German national. She has vast international business experience in the chemical industry.
The transition will begin immediately, and be completed by the end of next month. As of 1 August 2015, de Reuver will take on a new role in a corporate culture project, reporting to Dimitri de Vreeze, member of the DSM Managing Board.
Gerard de Reuver, a Dutch national, joined DSM in 2002 as Business Unit Director for Anti-Infectives. He later was named President of that unit, and Vice President of Crisis & Change. In March 2010 he accepted his current position. He saw the firm through its past five-year strategic business plan period, and played a key role in developing and strengthening the DSM Dyneema organization.
Golnar Motahari Pour, meanwhile, is already familiar with DSM Dyneema, having been engaged with the company in the last couple of months, as an independent business strategy and operations consultant. She is well versed in materials sciences. From 1993 to 2007 she held several management positions at General Electric Corp. in the Plastics, Silicones and Consumer Products businesses. Prior to joining DSM, Motahari Pour was a member of the European Executive Committee responsible for Emerald Kalama Chemical’s plasticizer business in Europe and the Middle East.
Golnar Motahari Pour holds a Master of Arts degree & Postgraduate Studies in Ecology from the Applied Sciences Faculty of the University of Brussels.
most read

MSD to Acquire Verona Pharma for $10 Billion
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.

Ineos Invests £30 Million to Slash Emissions at Hull Site by 75%
Ineos has completed a major £30 million investment at its Hull manufacturing site, converting the facility to run on clean-burning hydrogen instead of natural gas. This results in a 75% cut in carbon emissions.

Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.